Bosh sahifaDMYD-B • STO
add
Diamyd Medical AB
Yopilish kursi
17,18 kr
Kunlik diapazon
16,86 kr - 17,40 kr
Yillik diapazon
8,10 kr - 25,00 kr
Bozor kapitalizatsiyasi
1,76 mlrd SEK
Oʻrtacha hajm
251,02 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
STO
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (SEK) | noy, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 25,00 ming | -26,47% |
Joriy xarajat | 41,86 mln | 40,27% |
Sof foyda | -36,16 mln | -10,31% |
Sof foyda marjasi | -144,65 ming | -50,02% |
Har bir ulushga tushum | — | — |
EBITDA | -41,40 mln | -39,63% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (SEK) | noy, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 152,88 mln | -13,49% |
Jami aktivlari | 222,89 mln | -15,45% |
Jami passivlari | 66,78 mln | 25,66% |
Umumiy kapital | 156,11 mln | — |
Tarqatilgan aksiyalar | 104,09 mln | — |
Narxi/balansdagi bahosi | 11,45 | — |
Aktivlardan daromad | -48,78% | — |
Kapitaldan daromad | -71,05% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (SEK) | noy, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -36,16 mln | -10,31% |
Operatsiyalardan naqd pul | -41,82 mln | -50,37% |
Sarmoyadan naqd pul | 24,06 mln | 820,26% |
Moliyadan naqd pul | 59,07 mln | -27,87% |
Naqd pulning sof oʻzgarishi | 40,12 mln | -18,43% |
Boʻsh pul | -31,11 mln | -43,94% |
Haqida
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Tashkil etilgan
1984
Sayt
Xodimlar soni
29
